about
PET and MR imaging: the odd couple or a match made in heaven?A review of responsive MRI contrast agents: 2005-2014Potential clinical applications of bimodal PET-MRI or SPECT-MRI agentsAdvances in Magnetic Resonance Imaging Contrast Agents for Biomarker DetectionImproved pH measurements with a single PARACEST MRI contrast agentBiodistribution, kinetics, and biological fate of SPION microbubbles in the rat.Functional photoacoustic microscopy of pH.Redox- and hypoxia-responsive MRI contrast agents.Water soluble, cyclometalated Pt(ii)-Ln(iii) conjugates towards novel bimodal imaging agents.Concentration-independent MRI of pH with a dendrimer-based pH-responsive nanoprobeGadolinium Complex of (125)I/(127)I-RGD-DOTA Conjugate as a Tumor-Targeting SPECT/MR Bimodal Imaging Probe.Activatable T₁ and T₂ magnetic resonance imaging contrast agentsEu(III) complexes as anion-responsive luminescent sensors and paramagnetic chemical exchange saturation transfer agents.Serum albumin targeted, pH-dependent magnetic resonance relaxation agents.Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements.Quantitative cardiovascular magnetic resonance for molecular imaging.Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat modelStrategies for the preparation of bifunctional gadolinium(III) chelators.A smart magnetic resonance imaging contrast agent responsive to adenosine based on a DNA aptamer-conjugated gadolinium complex.Discrete bimodal probes for thrombus imaging.Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment.Simultaneous PET-MRI in oncology: a solution looking for a problem?Easy access to heterobimetallic complexes for medical imaging applications via microwave-enhanced cycloaddition.Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Redox-activated manganese-based MR contrast agentMRI biosensors: a short primer.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.MRI & MRS assessment of the role of the tumour microenvironment in response to therapy.Strategies for the development of gadolinium-based 'q'-activatable MRI contrast agents.The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.Environmentally responsive MRI contrast agents.Using lanthanide ions in molecular bioimaging.Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agentHybrid core shell nanoparticles entrapping Gd-DTPA and 18F-FDG for simultaneous PET/MRI acquisitions.Main applications of hybrid PET-MRI contrast agents: a review.Principles of Simultaneous PET/MR Imaging.Final step gallium-68 radiolabelling of silica-coated iron oxide nanorods as potential PET/MR multimodal imaging agents.Fluorine-18 labelled building blocks for PET tracer synthesis.Anchored proteinase-targetable optomagnetic nanoprobes for molecular imaging of invasive cancer cells.Next-generation imaging development for nanoparticle biodistribution measurements.
P2860
Q26851721-19697136-4646-406A-A779-74B174E8F016Q27009286-7B6945EA-F45F-439D-BE21-952B405E8D6BQ27026301-1E685133-E7CC-47B5-B721-44311AEF0B4FQ28830010-D0834B0A-C2E0-487A-8F0F-513B76D18FB5Q28833257-70480FB0-E5CB-4D05-94EE-EF9450958D72Q30449495-11BA3B90-4548-49A1-ADC2-82F8E08600C1Q30462527-61BCDDAF-CB32-4988-A7F4-D1B2A09E7026Q30820031-D70FE413-8F55-4251-B407-1B382E9CB361Q30978325-C4931DF9-E60F-4B82-8FB5-120EB4072709Q30980323-E5572E10-CA9B-4A80-8846-E1C12BABE38EQ33636069-11CF8106-1CD9-465F-8A0C-E28599EB37BDQ33823740-BF466F86-0C86-4350-9D40-8D0554A41438Q33891327-9C242C95-8A72-4E1F-BDD8-7F979726AD64Q34157012-F3FF2352-6881-4E90-974E-A0B67606B486Q34161695-E7438AD9-8481-46F1-BCC7-C66EA6D26A38Q34330885-D2D82D57-9CF1-417B-9A5A-D6088187B2D2Q34591066-69E13E6C-9829-4C55-874A-2DA8A6FC52B1Q35777941-7951F16A-358D-4642-A28C-22026E1FDCBAQ35819498-B044DDCE-DDE0-48D4-AD7B-2B02F7D9960EQ36095999-DB33918A-CC6E-4815-A843-8AA1BC8D4485Q36245012-D10171E6-A403-4323-8C22-E5EE1846CF78Q36303648-6F4D74D5-07E1-4B2E-99A2-7387A139A034Q36322217-DFE42D4A-6EFC-4C1C-8DA2-CD2C66C5C003Q36690711-2064204C-639D-4656-9772-5527DC574047Q36755361-9075867C-0A72-4765-B8DE-DE2FA17F95CDQ37143004-205031BC-B745-436C-9EBE-9FC0A0D19906Q37850696-4D03DAF2-F665-4E41-936D-905AF3CDB716Q37875004-F939673E-B8ED-4939-B0B6-C23D5D7B2C54Q38046790-AED28123-87A5-4C84-80CE-6C353E412B68Q38080002-5067493E-3A72-446A-8325-ECC41BB76764Q38138098-24320215-543C-47D7-9D55-95FF867A5AD0Q38318320-58371388-71AD-4EC3-8359-2AEC46B0CFDFQ38559085-7C4E02A0-3508-435D-B3AD-0DD79BF21189Q38621783-C20B2839-32D6-408B-9598-0823744AEFD5Q38657496-690C51FF-9BF5-4725-BD7E-2DEF05808E10Q38846615-349A15D8-D979-498B-8C21-AEF1BEF7B94AQ39111564-C0EAAB57-FB1A-4A4E-8089-74EC6CC8C796Q39369099-8C551E89-2FC6-4A4D-BD89-BD95B121023EQ39429329-133BF8AB-2A05-463E-B9FA-C073E77D7315Q39837631-328FEE38-3CC9-4982-96D5-0ADE17519379
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bimodal MR-PET agent for quantitative pH imaging.
@ast
Bimodal MR-PET agent for quantitative pH imaging.
@en
type
label
Bimodal MR-PET agent for quantitative pH imaging.
@ast
Bimodal MR-PET agent for quantitative pH imaging.
@en
prefLabel
Bimodal MR-PET agent for quantitative pH imaging.
@ast
Bimodal MR-PET agent for quantitative pH imaging.
@en
P2860
P50
P356
P1476
Bimodal MR-PET agent for quantitative pH imaging
@en
P2093
Luca Frullano
Thomas Benner
P2860
P304
P356
10.1002/ANIE.201000075
P407
P577
2010-03-01T00:00:00Z